Pathology: breast cancer - adjuvant; es-BC - TNBC - NA - all population; mBC - TNBC - L2 - all population;
breast cancer - adjuvant | es-BC - TNBC - NA - all population | mBC - TNBC - L2 - all population | ||
OlympiA (BIG 6-13, NSABP B-55), 0 | OlympiA (BIG 6-13, NSABP B-55), 0 | OlympiAD, 2017 | ||
olaparib | 3 | T1 | T1 | T1 |
placebo | 0 | T0 | T0 | |
Standard of Care (SoC) | 0 | T0 |